Antimicrobial Resistance in Bovine Respiratory Disease Pathogens: Measures, Trends, and Impact on Efficacy

Veterinary Clinics of North America - Food Animal Practice

Volumn 26, Issue 1, 2010, Pages 79-88

  Watts, Jeffrey L ^a   Sweeney, Michael T ^a  

^a PFIZER INC   (United States)

Author keywords

Antimicrobial resistance; Antimicrobial susceptibility tests; Bovine respiratory disease; Surveillance program

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; BACTERIUM; CATTLE; CATTLE DISEASE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RESPIRATORY TRACT DISEASE; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT DISEASES;

BOS; BOVINAE;

EID: 73349093757     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2009.10.009     Document Type: Review

References (27)

1. USDA Part I: baseline reference of feedlot management practices, 1999. Fort Collins (CO): USDA: APHIS: VS, CEAH, National Animal Health Monitoring System; 2000: N327.0500.
2. USDA. Part II: baseline reference of feedlot health and health management, 1999 (2000), USDA: APHIS: VS, CEAH, National Animal Health Monitoring System, Fort Collins (CO) N335.1000
3. USDA. Part III: health management and biosecurity in U.S. feedlots, 1999 (2000), USDA: APHIS: VS, CEAH, National Animal Health Monitoring System, Fort Collins (CO) N336.1200
4. Mosier D.A. Bacterial pneumonia, bovine respiratory disease update. Vet Clin North Am 13 (1997) 483-493
5. Loneragan G.H., Dargatz D.A., Morley P.S., et al. Trends in mortality ratios among cattle in US feedlots. J Am Vet Med Assoc 219 (2001) 1122-1127
6. Nutsch R.G., Skogerboe T.L., Rooney K.A., et al. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Vet Ther 6 (2005) 167-179
7. Van Donkersgoed J., Berg J., and Hendrick S. Comparison of florfenicol and tulathromycin for the treatment of undifferentiated fever in Alberta feedlot cattle. Vet Ther 9 (2008) 275-281
8. CLSI. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard. 3rd edition. CLSI document M31-A3 (2008), Clinical and Laboratory Standards Institute, Wayne (PA)
9. CLSI. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents: approved guideline. 3rd edition. CLSI document M37-A3 (2008), Clinical and Laboratory Standards Institute, Wayne (PA)
10. Catry B., Haesebrouck F., De Vliegher S., et al. Variability in acquired resistance of Pasteurella and Mannheimia isolates from the nasopharynx of calves, with particular reference to different herd types. Microb Drug Resist 11 4 (2005) 387-394
11. Schwarz S., Kehrenberg C., Salmon S., et al. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle. J Antimicrob Chemother 53 (2004) 379-382
12. Priebe S., and Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrobial Agents Chemother 47 8 (2003) 2703-2705
13. Godinho K.S. Susceptibility testing of tulathromycin: interpretive breakpoints and susceptibility of field isolates. Vet Microbiol 129 (2008) 426-432
14. Watts J.L., and Yancey Jr. R.J. Identification of veterinary pathogens using commercial identification systems and new trends in antimicrobial susceptibility testing of veterinary pathogens. Clin Microbiol Rev 7 (1994) 346-356
15. Simjee S., Silley P., Werling H.O., et al. Potential confusion regarding the term "resistance" in epidemiological studies. J Antimicrob Chemother 61 (2008) 228-229
16. Kehrenberg C., Walker R.D., Wu C.C., et al. Antimicrobial resistance in members of the family Pasteurellaceae. In: Aarestrup F.M. (Ed). Antimicrobial resistance in bacteria of animal origin (2006), ASM Press, Washington, DC 167-186
17. Watts J.L., Yancey Jr. R.J., Salmon S.A., et al. A four-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease cases in North America. J Clin Microbiol 32 (1994) 725-731
18. Evans N. Tulathromycin: an overview of a new triamilides antimicrobial for livestock respiratory disease. Vet Ther 6 (2005) 83-95
19. Guardabassi L., and Courvalin P. Modes of antimicrobial action and mechanisms of bacterial resistance. In: Aarestrup F.M. (Ed). Antimicrobial resistance in bacteria of animal origin (2006), ASM press, Washington, DC 1-18
20. Godinho K.S., Keane S.G., Nanjiani I.A., et al. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet Ther 6 (2005) 113-121
21. Katsuda K., Kohmoto M., Mikami O., et al. Antimicrobial resistance and genetic characterization of fluoroquinolone-resistant Mannheimia haemolytica isolates from cattle with bovine pneumonia. Vet Microbiol (2009) 10.1016/j.vetmic.2009.04.020
22. Aarestrup F.M., and Schwarz S. Antimicrobial resistance in staphylococci and streptococci of animal origin. In: Aarestrup F.M. (Ed). Antimicrobial resistance in bacteria of animal origin (2006), ASM press, Washington, DC 187-212
23. Blasi F., Aliberti S., Pappalettera M., et al. 100 years of respiratory medicine: pneumonia. Respir Med 101 (2007) 875-881
24. Feikin D., Schuchat A., Kolczak M., et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 90 (2000) 223-229
25. Kilgore W.R., Spensley M.S., Sun F., et al. Clinical effectiveness of tulathromycin, a novel triamilides antimicrobial, for control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther 6 (2005) 136-142
26. Apley M.D. Susceptibility testing for bovine respiratory and enteric disease. Vet Clin North Am Food Anim Pract 19 (2003) 625-646
27. Watts JL. The clinical relevance of susceptibility breakpoints. Proceedings of the Antimicrobial Agents in Veterinary Medicine Meeting. Prague (Czech Republic); August 24-8, 2008.